Recent Quotes
My Watchlist
Indicators
Local Stocks
NewsOK Local Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Inovio Pharma (NQ: INO )

13.62 USD +3.04 (+28.78%)
Streaming Delayed Price Updated: 2:32 PM EST, Jan 27, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press releases about Inovio Pharma

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Inovio Receives $24 Million Option Grant From DARPA to Advance Ebola Program Development
Clinical Trial Fully Enrolled; Vaccine Protected 100% of Monkeys in Ebola Virus Challenge 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Publishes Successful Phase 2b Trial Results of Its HPV Immunotherapy in The Lancet
Distinguished Medical Journal Reports Killer T Cells Produced by Immunotherapy Regress High Grade Cervical Neoplasia and Clears HPV Infection 
From GlobeNewswire News Releases
Inovio's Chief Operating Officer Selected by PharmaVoice as One of the Most Inspirational Leaders in the Global Industry
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced today that PharmaVoice, one of the leading industry publications in the life sciences industry, has selected Dr. Niranjan Sardesai as one of its 100... 
From GlobeNewswire News Releases
Critical Alerts For Apple, The Kroger Co, Costco, Inovio Pharmaceuticals and Alibaba Released By InvestorsObserver
InvestorsObserver issues critical PriceWatch Alerts for AAPL, KR, COST, INO and BABA. 
From PR Newswire
Inovio Pharmaceuticals Announces First Patient Dosed With Universal HIV Vaccine
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Participate in Citi and Rodman & Renshaw Investor Conferences
From GlobeNewswire News Releases
Critical Alerts For Linn Energy, Salesforce.com, Intrexon, Twitter and Inovio Pharmaceuticals Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals DNA Vaccine Protects 100% Against Deadly MERS Virus in Non-Human Primates
Promising Data on Preventive Vaccine Appears in the Peer-Reviewed Journal Science Translational Medicine 
From GlobeNewswire News Releases
Critical Alerts For Fitbit, Boeing, Inovio Pharmaceuticals, JetBlue and ACADIA Pharmaceuticals Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals Reports 2015 Second Quarter Results; Conference Call Will Discuss New Cancer Partnership
Go to inovio.com at 8:30 a.m. ET Today and Click on "Webcast" to Join the Call 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
From GlobeNewswire News Releases
Critical Alerts For Juno Therapeutics Inc, Inovio Pharmaceuticals, Microsoft, Yahoo! and Vivint Solar Inc Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals to Host Second Quarter 2015 Financial Results Conference Call August 10, 2015
From GlobeNewswire News Releases
Inovio Pharmaceuticals' DNA-Based Monoclonal Antibody Protects Animals Against Lethal Challenge
From GlobeNewswire News Releases
Inovio Pharmaceuticals Initiates Clinical Trial of INO-5150 DNA Immunotherapy for Prostate Cancer
Inovio's Focus on Taking Immunotherapy to the Next Level Expands Into Prostate Cancer 
From GlobeNewswire News Releases
Inovio Pharmaceuticals and European Organization for Research and Treatment of Cancer to Collaborate on Large Phase II Cervical Cancer Trial
Partnership With Europe's Largest Cancer Research Organization Will Benefit Inovio in Faster European Recruiting and Clinical Results 
From GlobeNewswire News Releases
Inovio's CEO Appointed to Aspen Institute's Health Innovators Fellowship
Immunotherapy Pioneer Will Work With Other Business and Medical Leaders to Create New Approaches to Improve Healthcare 
From GlobeNewswire News Releases
Rodman & Renshaw 2015 Annual Global Investment Conference to be held in New York from September 8 to 10, 2015
From PR Newswire
Critical Alerts For Alcoa, VASCO Data Security, Zillow, Inovio Pharmaceuticals and Kite Pharma Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" by Ernst & Young
Dr. J. Joseph Kim Selected for Philadelphia Region Award 
From GlobeNewswire News Releases
Critical Alerts For Abercrombie & Fitch, Inovio Pharmaceuticals, Wynn Resorts, Mylan and Netflix Released By InvestorsObserver
From PR Newswire
Inovio Pharmaceuticals Partners with GeneOne Life Science for MERS Immunotherapy Clinical Development
Lethal Middle East Respiratory Syndrome Kills 40% of Those Infected; Human-to-Human Transmission of the Virus has Occurred in South Korea 
From GlobeNewswire News Releases
Inovio to Present at Jefferies Healthcare Conference
From GlobeNewswire News Releases
Critical Alerts For Apple, Freeport-McMoRan, Celgene, Inovio Pharmaceuticals and Ambarella Released By InvestorsObserver
From PR Newswire
Critical Alerts For Inovio Pharmaceuticals, TrueCar, HealthStream, Nuance Communications and Kinder Morgan Released By InvestorsObserver
From PR Newswire
Inovio Initiates Clinical Trial With DNA Immunotherapies to Prevent and Treat Ebola
First Step in DARPA-Funded $45 Million Program 
From GlobeNewswire News Releases
Inovio Pharmaceuticals Reports 2015 First Quarter Financial Results
From GlobeNewswire News Releases
Inovio Pharmaceuticals Closes $87.4 Million Underwritten Financing
From GlobeNewswire News Releases
Inovio Pharmaceuticals to Report First Quarter 2015 Financial Results May 11, 2015
From GlobeNewswire News Releases
Inovio Pharmaceuticals Announces Pricing of Public Offering of Common Stock
From GlobeNewswire News Releases
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.